Supplemental Table S3. Demographic, clinical, and pathological characteristics of 25 men with biochemical recurrent prostate cancer

Patient No. / Age (years) / Ethnicity / Gleason Score / Clinical Stage / Primary Treatment / Follow-up Treatment
1 / 81 / White / unknown / pT3bN0Mx / prostatectomy
2 / 70 / African-American / 4+4=8 / pT3bN0Mx / prostatectomy
3 / 63 / White / 4+3=7 / pT2aNxMx / prostatectomy
4 / 78 / White / 3+4=7 / pT2bNxMx / prostatectomy / salvage XBRT
5 / 67 / White / unknown / pT3?NxMx / prostatectomy / salvage XBRT & AAT
6 / 71 / White / unknown / unknown / prostatectomy / salvage XBRT
7 / 65 / White / 4+5=9 / pT3aNxMx / prostatectomy / salvage XBRT & AAT
8 / 74 / White / 3+3=6 / unknown / Brachy
9 / 75 / White / 4+3=7 / pT3aN0Mx / prostatectomy
10 / 64 / White-Hispanic / 4+5=9 / pT3bN0Mx / prostatectomy
11 / 70 / White / 4+4=8 / pT3bN0Mx / prostatectomy
12 / 83 / White / 5+3=8 / pT3?N0Mx / prostatectomy / salvage XBRT & AAT
13 / 67 / White / 3+3=6 / pT2aN0Mx / prostatectomy / adjuvant XBRT & AAT
14 / 60 / White / 3+3=6 / pT2?N0Mx / prostatectomy
15 / 69 / White / 4+5=9 / pT1cN0M0 / XBRT & Brachy
16 / 77 / White / 3+3=6 / unknown / cryotherapy
17 / 52 / White / 4+4=8 / pT3bN0Mx / prostatectomy / salvage XBRT & AAT
18 / 58 / White / 3+3=6 / pT2cN0Mx / prostatectomy / salvage XBRT
19 / 70 / White / 4+3=7 / pT2cR1N0Mx / prostatectomy
20 / 70 / White / 4+4=8 / pT3bN0Mx / prostatectomy
21 / 64 / White / 4+4=8 / pT3aN0M0 / prostatectomy / salvage XBRT
22 / 70 / White / 4+5=9 / pT3bN1Mx / prostatectomy / AAT
23 / 68 / African-American / 3+4=7 / unknown / none
24 / 76 / White / 4+4=8 / pT3bN1Mx / prostatectomy / AAT
25 / 72 / White / 4+3=7 / pT1cN0M0 / XBRT & Brachy

*Brachy, brachytherapy; XBRT, external beam radiation therapy; AAT, androgen ablation therapy.